Cordula Bittner

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. ncbi Identification of wheat gliadins as an allergen family related to baker's asthma
    Cordula Bittner
    Institute of Occupational Medicine and Maritime Medicine ZfAM, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Allergy Clin Immunol 121:744-9. 2008
  2. ncbi Cof a 1: identification, expression and immunoreactivity of the first coffee allergen
    Nikolay Manavski
    Biocenter Klein Flottbek and Botanical Garden, University of Hamburg, Hamburg, Germany
    Int Arch Allergy Immunol 159:235-42. 2012
  3. ncbi Whole cell ELISA for measuring anti-tumour effects of immunotherapies in a mouse tumour model of ALCL
    Merwe Carstens
    Department of Pathology, Medical University of Luebeck, Luebeck, Germany
    In Vivo 17:359-63. 2003

Collaborators

  • Xaver Baur
  • Marcus Oldenburg
  • Nikolay Manavski
  • Merwe Carstens
  • Ulrike Peters
  • Reinhold Brettschneider
  • Marco Hadlak
  • Hartmut Merz
  • Alfred C Feller
  • Manuela Krokowski

Detail Information

Publications3

  1. ncbi Identification of wheat gliadins as an allergen family related to baker's asthma
    Cordula Bittner
    Institute of Occupational Medicine and Maritime Medicine ZfAM, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Allergy Clin Immunol 121:744-9. 2008
    ..Therefore the reliability of current diagnostic procedures is insufficient. Only few of the suspected causative wheat allergens have been hitherto characterized on the molecular level...
  2. ncbi Cof a 1: identification, expression and immunoreactivity of the first coffee allergen
    Nikolay Manavski
    Biocenter Klein Flottbek and Botanical Garden, University of Hamburg, Hamburg, Germany
    Int Arch Allergy Immunol 159:235-42. 2012
    ..Conclusions: A class III chitinase of C. arabica was identified to be the first known coffee allergen Cof a 1. It may have a relevant potential for the specific diagnosis of coffee sensitization...
  3. ncbi Whole cell ELISA for measuring anti-tumour effects of immunotherapies in a mouse tumour model of ALCL
    Merwe Carstens
    Department of Pathology, Medical University of Luebeck, Luebeck, Germany
    In Vivo 17:359-63. 2003
    ..We conclude that this therapy may be a new attractive part of a tumour immunization strategy...